<?xml version="1.0" encoding="UTF-8"?>
<p class="p">There are numerous studies confirming the anticancer activity of oleuropein, as observed in human cancer cell lines, such as: breast adenocarcinoma (cell line MCF-7, MDA) [
 <xref rid="B83-ijms-19-00686" ref-type="bibr" class="xref">83</xref>,
 <xref rid="B84-ijms-19-00686" ref-type="bibr" class="xref">84</xref>,
 <xref rid="B85-ijms-19-00686" ref-type="bibr" class="xref">85</xref>,
 <xref rid="B86-ijms-19-00686" ref-type="bibr" class="xref">86</xref>,
 <xref rid="B87-ijms-19-00686" ref-type="bibr" class="xref">87</xref>], melanoma (cell line RPMI 7951) [
 <xref rid="B86-ijms-19-00686" ref-type="bibr" class="xref">86</xref>], urinary bladder carcinoma (cell line T-24) [
 <xref rid="B86-ijms-19-00686" ref-type="bibr" class="xref">86</xref>], colorectal adenocarcinoma (cell line HT 29, Caco-2, LoVo) [
 <xref rid="B86-ijms-19-00686" ref-type="bibr" class="xref">86</xref>,
 <xref rid="B88-ijms-19-00686" ref-type="bibr" class="xref">88</xref>,
 <xref rid="B89-ijms-19-00686" ref-type="bibr" class="xref">89</xref>], prostate cancer (cell line TF1) [
 <xref rid="B87-ijms-19-00686" ref-type="bibr" class="xref">87</xref>], lung carcinoma (cell line A549) [
 <xref rid="B90-ijms-19-00686" ref-type="bibr" class="xref">90</xref>], glioblastoma (cell line LN 18), renal cell adenocarcinoma (cell line 786-O) [
 <xref rid="B87-ijms-19-00686" ref-type="bibr" class="xref">87</xref>], and glioma (cell line U251, A172) [
 <xref rid="B91-ijms-19-00686" ref-type="bibr" class="xref">91</xref>].
</p>
